Araki Takashi, Morimoto Ryota, Ito Ryota, Mizutani Takashi, Kimura Yuki, Kazama Shingo, Oishi Hideo, Kuwayama Tasuku, Hiraiwa Hiroaki, Kondo Toru, Okumura Takahiro, Murohara Toyoaki
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
CJC Open. 2022 Jul;4(7):656-659. doi: 10.1016/j.cjco.2022.03.008. Epub 2022 Mar 24.
A 53-year-old woman with no significant medical history developed cardiogenic shock 4 days after receiving the second dose of the COVID-19 mRNA vaccine (BNT162b2, Pfizer/BioNtech). The patient required extracorporeal membrane oxygenation and an Impella device. Based on significant hemoconcentration, decreased plasma protein levels, and pathologic findings in myocardial specimens, the patient was diagnosed with vaccination-induced fulminant systemic capillary leak syndrome (SCLS) with severe cardiac dysfunction. This case highlights that SCLS can occur after COVID-19 mRNA vaccination and may be associated with cardiac dysfunction. In patients with cardiogenic shock, hemoconcentration, and hypoalbuminemia after vaccination, SCLS should be considered.
一名53岁无重大病史的女性在接种第二剂新冠病毒mRNA疫苗(BNT162b2,辉瑞/ BioNTech)4天后发生心源性休克。患者需要体外膜肺氧合和Impella装置。基于显著的血液浓缩、血浆蛋白水平降低以及心肌标本的病理结果,该患者被诊断为接种疫苗后诱发的暴发性全身性毛细血管渗漏综合征(SCLS)并伴有严重的心功能不全。该病例突出表明SCLS可在新冠病毒mRNA疫苗接种后发生,且可能与心功能不全有关。对于接种疫苗后出现心源性休克、血液浓缩和低白蛋白血症的患者,应考虑SCLS。